Loading clinical trials...
Loading clinical trials...
Phase 1, Open-label Study of the Safety, Tolerability, and Histological Effect of Single Doses of ATX-101 (Sodium Deoxycholate for Injection) Administered in Abdominal Fat in Subjects Undergoing Abdominoplasty
Histopathological study of abdominal fat excised from subjects undergoing abdominoplasty
Age
25 - 65 years
Sex
ALL
Healthy Volunteers
Yes
San Francisco, California, United States
Santa Monica, California, United States
Start Date
November 1, 2008
Primary Completion Date
March 1, 2009
Completion Date
April 1, 2009
Last Updated
January 27, 2010
14
ESTIMATED participants
ATX-101
DRUG
Lead Sponsor
Kythera Biopharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions